3 Critical Things Investors Should Look for Before Buying Clinical-Stage Biotech Stocks

Keith Speights and Brian Orelli, PhD, The Motley Fool
·3-min read

In this Motley Fool Live video, recorded on March 31, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss three critical things investors should look for before buying clinical-stage biotech stocks. Keith Speights: There is some news from last week that you and I didn't get a chance to talk about.